Episodes 1-15 of 26
Understanding Disparities in AD
Practical Dermatology: Atopic DermatitisUnderstanding Disparities in AD
DermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
Practical Dermatology: Atopic DermatitisDermWire TV Extra: 3-Year Clinical Data on Lebrikizumab
New Drugs Helping AD Catch Up to Psoriasis
Practical Dermatology: Atopic DermatitisNew Drugs Helping AD Catch Up to Psoriasis
Addressing the Unique Challenges of AD Patients
Practical Dermatology: Atopic DermatitisAddressing the Unique Challenges of AD Patients
FDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
Practical Dermatology: Atopic DermatitisFDA Approves Eli Lilly’s AD Drug Ebglyss (Lebrikizumab)
Itching for More: Treatment Options Continue to Expand for Itch and Pain
Practical Dermatology: Atopic DermatitisItching for More: Treatment Options Continue to Expand for Itch and Pain
ISDPA: Dr. Bhatia on JAK Inhibitors
Practical Dermatology: Atopic DermatitisISDPA: Dr. Bhatia on JAK Inhibitors
ISDPA: Dr. Bhatia and Dr. Zirwas Discuss the Itchy Patient
Practical Dermatology: Atopic DermatitisISDPA: Dr. Bhatia and Dr. Zirwas Discuss the Itchy Patient
Study Examines Association Between Childhood BMI and Risk of Developing IMSDs
Practical Dermatology: Atopic DermatitisStudy Examines Association Between Childhood BMI and Risk of Developing IMSDs
Pearls for Monitoring and Managing Itch: An Expert Panel
Practical Dermatology: Atopic DermatitisPearls for Monitoring and Managing Itch: An Expert Panel
Talking to Patients About Starting a JAK Inhibitor in Atopic Dermatitis
Practical Dermatology: Atopic DermatitisTalking to Patients About Starting a JAK Inhibitor in Atopic Dermatitis
Upadacitinib Therapy in a Pediatric Patient with Infliximab-Induced Skin Eruption
Practical Dermatology: Atopic DermatitisUpadacitinib Therapy in a Pediatric Patient with Infliximab-Induced Skin Eruption
DERM2024: Dr. Friedman on Atopic Dermatitis Diagnosis
Practical Dermatology: Atopic DermatitisDERM2024: Dr. Friedman on Atopic Dermatitis Diagnosis
